Journal article
In adults at high CV risk and without previous MI or stroke, evolocumab reduced major adverse CV event composites at a median 4.6 y
Annals of internal medicine
03 Mar 2026
PMID: 41771125
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
GIM/FP/GP: [Formula: see text] Cardiology: [Formula: see text].
Metrics
3 Record Views
Details
- Title
- In adults at high CV risk and without previous MI or stroke, evolocumab reduced major adverse CV event composites at a median 4.6 y
- Creators
- Anthony Donato - Reading HospitalACP Journal Club Editorial Team at McMaster University
- Publication Details
- Annals of internal medicine
- Publisher
- AMER COLL PHYSICIANS; PHILADELPHIA
- Number of pages
- 1
- Grant note
- American College of Physicians
Funding for ACP Journal Club is provided by the American College of Physicians. ACP Journal Club is editorially independent from Annals of Internal Medicine.
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Medicine (Graduate); General Internal Medicine
- Web of Science ID
- WOS:001706528200001
- Scopus ID
- 2-s2.0-105033102838
- Other Identifier
- 991022166479504721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
Source: SDGs in the Output
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Medicine, General & Internal